Literature DB >> 1399134

PCR assay for chromosome 1p deletion in small neuroblastoma samples.

M Peter1, J Michon, P Vielh, S Neuenschwander, Y Nakamura, E Sonsino, J M Zucker, G Vergnaud, G Thomas, O Delattre.   

Abstract

Deletion of the short arm of chromosome 1 is among the most recurrent cytogenetic alterations found in neuroblastoma and has been associated with short survival. However, this prognostic information, which relies on time-consuming techniques, is not yet routinely exploited. In order to set up a reliable and simple routine test to determine 1p deletion in neuroblastoma, we have used the polymerase chain reaction to genotype neuroblastoma DNA at 2 loci containing a variable number of tandem repeats and located on the distal part of the short arm of chromosome 1. Agarose gel electrophoresis and ethidium bromide staining of the amplification products enable a simple determination of constitutional and tumor genotypes at these loci to be made. A total of 37 samples from 29 patients were studied with this technique. Loss of heterozygosity (LOH) could be identified in 8 cases. In each case the results obtained were in agreement with those achieved by the Southern procedure. This technique will be of particular interest in the pretherapeutic analysis of 1p deletions in small tumor samples obtained by fine-needle aspirates of the primary tumor. It should also enable retrospective studies from paraffin-embedded tumor fragments to be made and provide information for the analysis of tumor heterogeneity in neuroblastoma and in other tumors with 1p deletions.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1399134     DOI: 10.1002/ijc.2910520408

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  7 in total

Review 1.  Clinical categories of neuroblastoma are associated with different patterns of loss of heterozygosity on chromosome arm 1p.

Authors:  J Mora; N K Cheung; B H Kushner; M P LaQuaglia; K Kramer; M Fazzari; G Heller; L Chen; W L Gerald
Journal:  J Mol Diagn       Date:  2000-02       Impact factor: 5.568

Review 2.  Neuroblastoma tumour genetics: clinical and biological aspects.

Authors:  N Bown
Journal:  J Clin Pathol       Date:  2001-12       Impact factor: 3.411

3.  Detection of MYCN amplification and chromosome 1p36 loss in neuroblastoma by cDNA microarray comparative genomic hybridization.

Authors:  Paola Scaruffi; Stefano Parodi; Katia Mazzocco; Raffaella Defferrari; Vincenzo Fontana; Stefano Bonassi; Gian Paolo Tonini
Journal:  Mol Diagn       Date:  2004

4.  DeltaN-p73alpha accumulates in human neuroblastic tumors.

Authors:  Sétha Douc-Rasy; Michel Barrois; Maria Echeynne; Mourad Kaghad; Etienne Blanc; Gilda Raguenez; David Goldschneider; Marie-José Terrier-Lacombe; Olivier Hartmann; Ute Moll; Daniel Caput; Jean Bénard
Journal:  Am J Pathol       Date:  2002-02       Impact factor: 4.307

Review 5.  Familial breast cancer and genes involved in breast carcinogenesis.

Authors:  A Lindblom
Journal:  Breast Cancer Res Treat       Date:  1995-05       Impact factor: 4.872

6.  Numerical and structural aberrations in advanced neuroblastoma tumours by CGH analysis; survival correlates with chromosome 17 status.

Authors:  C L Cunsolo; M P Bicocchi; A R Petti; G P Tonini
Journal:  Br J Cancer       Date:  2000-11       Impact factor: 7.640

7.  Fluorescence in situ hybridization techniques for the rapid detection of genetic prognostic factors in neuroblastoma. United Kingdom Children's Cancer Study Group.

Authors:  C P Taylor; N P Bown; A G McGuckin; J Lunec; A J Malcolm; A D Pearson; D Sheer
Journal:  Br J Cancer       Date:  2000-07       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.